131 related articles for article (PubMed ID: 11726135)
1. Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus.
Okamoto M; Ohe G; Oshikawa T; Furuichi S; Nishikawa H; Tano T; Ahmed SU; Yoshida H; Moriya Y; Saito M; Sato M
Cancer Immunol Immunother; 2001 Oct; 50(8):408-16. PubMed ID: 11726135
[TBL] [Abstract][Full Text] [Related]
2. Induction of Th1-type cytokines by lipoteichoic acid-related preparation isolated from OK-432, a penicillin-killed streptococcal agent.
Okamoto M; Ohe G; Oshikawa T; Nishikawa H; Furuichi S; Yoshida H; Matsuno T; Saito M; Sato M
Immunopharmacology; 2000 Sep; 49(3):363-76. PubMed ID: 10996034
[TBL] [Abstract][Full Text] [Related]
3. Severe impairment of anti-cancer effect of lipoteichoic acid-related molecule isolated from a penicillin-killed Streptococcus pyogenes in toll-like receptor 4-deficient mice.
Okamoto M; Oshikawa T; Ohe G; Nishikawa H; Furuichi S; Tano T; Moriya Y; Saito M; Sato M
Int Immunopharmacol; 2001 Sep; 1(9-10):1789-95. PubMed ID: 11562070
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.
Okamoto M; Ohe G; Furuichi S; Nishikawa H; Oshikawa T; Tano T; Ahmed SU; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
Anticancer Res; 2002; 22(6A):3229-39. PubMed ID: 12530069
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432, a streptococcal preparation.
Okamoto M; Gohda H; Ohe G; Yoshida H; Matsuno T; Saito M; Sato M
J Immunother; 2000 Jan; 23(1):94-103. PubMed ID: 10687142
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cytokine-inducing activity in a lipoteichoic acid-related molecule isolated from a penicillin-killed group A Streptococcus and from untreated bacteria.
Okamoto M; Oshikawa T; Ohe G; Furuichi S; Nishikawa H; Tano T; Bando T; Yoshida H; Matsubara S; Matsuno T; Saito M; Sato M
Int Immunopharmacol; 2001 Oct; 1(11):1957-68. PubMed ID: 11606027
[TBL] [Abstract][Full Text] [Related]
8. Th1-cytokine induction and anti-tumor effect of 55 kDa protein isolated from Aeginetia indica L., a parasitic plant.
Ohe G; Okamoto M; Oshikawa T; Furuichi S; Nishikawa H; Tano T; Uyama K; Bando T; Yoshida H; Sakai T; Himeno K; Sato M; Ohkubo S
Cancer Immunol Immunother; 2001 Jul; 50(5):251-9. PubMed ID: 11499808
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of interferon-gamma-inducing molecule of OK-432, a penicillin-killed streptococcal preparation, by monoclonal antibody neutralizing interferon-gamma-inducing activity of OK-432.
Okamoto M; Kaji R; Kasetani H; Yoshida H; Moriya Y; Saito M; Sato M
J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):232-42. PubMed ID: 8334107
[TBL] [Abstract][Full Text] [Related]
10. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of OK-432-derived DNA: one of the active constituents of OK-432, a streptococcal immunotherapeutic agent.
Oshikawa T; Okamoto M; Tano T; Sasai A; Kan S; Moriya Y; Ryoma Y; Saito M; Akira S; Sato M
J Immunother; 2006; 29(2):143-50. PubMed ID: 16531815
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of cytokine-inducing protein of seed extract from Aeginetia indica L., a parasitic plant.
Okamoto M; Ohe G; Oshikawa T; Nishikawa H; Furuichi S; Bando T; Yoshida H; Sakai T; Himeno K; Sato M; Ohkubo S
Immunopharmacology; 2000 Sep; 49(3):377-89. PubMed ID: 10996035
[TBL] [Abstract][Full Text] [Related]
13. Lipoteichoic acid-related molecule derived from the streptococcal preparation, OK-432, which suppresses atopic dermatitis-like lesions in NC/Nga mice.
Horiuchi Y; Bae S; Katayama I; Oshikawa T; Okamoto M; Sato M
Arch Dermatol Res; 2006 Sep; 298(4):163-73. PubMed ID: 16845523
[TBL] [Abstract][Full Text] [Related]
14. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state.
Fujimoto T; Duda RB; Szilvasi A; Chen X; Mai M; O'Donnell MA
J Immunol; 1997 Jun; 158(12):5619-26. PubMed ID: 9190909
[TBL] [Abstract][Full Text] [Related]
15. Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities.
Takada H; Kawabata Y; Arakaki R; Kusumoto S; Fukase K; Suda Y; Yoshimura T; Kokeguchi S; Kato K; Komuro T
Infect Immun; 1995 Jan; 63(1):57-65. PubMed ID: 7806384
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/Nga mice: possible shift from a Th2- to Th1-predominance.
Horiuchi Y; Bae S; Katayama I; Nishioka K
J Dermatol Sci; 2004 Sep; 35(3):187-97. PubMed ID: 15381240
[TBL] [Abstract][Full Text] [Related]
17. Analysis of antitumor effects of OK-432 against syngeneic mouse fibrosarcoma: combination effect of OK-432 and recombinant lymphokines.
Nanjo M; Moriya Y; Hashimoto S; Kataoka M; Saito M; Yoshida T; Ishida N
Int J Immunopharmacol; 1991; 13(2-3):205-15. PubMed ID: 1906439
[TBL] [Abstract][Full Text] [Related]
18. Antitumour effects of streptococcal lipoteichoic acids on Meth A fibrosarcoma.
Usami H; Yamamoto A; Yamashita W; Sugawara Y; Hamada S; Yamamoto T; Kato K; Kokeguchi S; Ohokuni H; Kotani S
Br J Cancer; 1988 Jan; 57(1):70-3. PubMed ID: 3279996
[TBL] [Abstract][Full Text] [Related]
19. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of antitumor effect on mouse hepatocellular carcinoma by intratumoral injection of OK-432, a streptococcal preparation.
Homma S; Sagawa Y; Komita H; Koido S; Nagasaki E; Ryoma Y; Okamoto M
Cancer Immunol Immunother; 2007 Aug; 56(8):1265-74. PubMed ID: 17219148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
